Loading...

Tianda Pharmaceuticals Limited

0455.HKHKSE
HealthcareDrug Manufacturers - Specialty & Generic
HK$0.14
HK$0.00(0.00%)

Tianda Pharmaceuticals Limited 0455.HK Peers

See (0455.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
0455.HKHK$0.14N/A303.2M-4.70-HK$0.03N/A
3692.HKHK$25.85-0.77%153.7B32.31HK$0.80N/A
2196.HKHK$16.44+9.89%62.4B13.70HK$1.20+1.99%
0874.HKHK$17.44-0.57%44.5B9.64HK$1.81+7.90%
1513.HKHK$29.05+0.69%32.4B11.62HK$2.50+5.56%
3320.HKHK$5.15-0.39%32.4B8.88HK$0.58+6.15%
0512.HKHK$8.64-0.92%30.3B12.34HK$0.70+6.02%
3933.HKHK$14.62+4.73%26.6B9.08HK$1.61+4.21%
0867.HKHK$10.72+1.13%25.9B14.68HK$0.73+2.96%
0013.HKHK$22.45+2.28%19.6B72.42HK$0.31N/A
Showing 1 to 10 of 42 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

0455.HK vs 3692.HK Comparison

0455.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0455.HK stands at 303.2M. In comparison, 3692.HK has a market cap of 153.7B. Regarding current trading prices, 0455.HK is priced at HK$0.14, while 3692.HK trades at HK$25.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0455.HK currently has a P/E ratio of -4.70, whereas 3692.HK's P/E ratio is 32.31. In terms of profitability, 0455.HK's ROE is -0.15%, compared to 3692.HK's ROE of +0.15%. Regarding short-term risk, 0455.HK is more volatile compared to 3692.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0455.HK.

Stock Price Comparison

Loading...

Frequently Asked Questions